We’re pretty sure most of OBC’s female members are pretty a-ok with their sex drive, but we also know that lots of times, women find themselves feeling… off. Not as sexy, or sexual, or into sex as their used to. And unlike men, whose sexual “dysfunctions” have a PLETHORA of treatments, women’s low sex-drive is often ignored, most likely because someone women who enjoy sex are still considered sluts, even though it’s 2015 and you can print a F*CKING GUN.

Needless to say, we’re pretty stoked any time we hear that doctors and scientists are talking about female sexuality and researching how they can help women who struggle with sexual issues. Take, for example, a libido-boosting drug by Sprout Pharmaceuticals that is currently trying to claw its way through through the FDA. Via NPR:

“Up until now,” she says, “the treatment paradigm for women with sexual dysfunction has essentially been: Let’s take a drug that works in men and let’s see if it works in women.”

None of them did. But Sprout’s drug, flibanserin, takes a totally different approach than, say, Viagra. Instead of increasing blood flow to the genitals, flibanserin affects a different part of the body: the brain.

Flibanserin shifts the balance of three key brain chemicals, Whitehead says. The drug, she says, increases “excitatory factors for sex” — dopamine and norepinephrine — and decreases serotonin, which can dampen the sex drive.

Apparently, the drug isn’t having much success in the FDA because they don’t think it’s all that effective, and are worried it may negatively interact with any anti-depressants a woman is on, which is an understandable issue (then again, more booty calls relieve stress which could help depression, so…). However, here’s to hoping it gets through, since the makers of the drug claim they were able to boost “desire by 53 percent, and doubled their number of satisfying sexual events.”

Sounds like a win to us!